Back
Innate Pharma SA Vs. UnitedHealth Group Industry Stock Comparison
Sell
46
IPHA
Innate Pharma SA
Last Price:
$2.05
Seasonality Move:
-8.32%
Sell
14
UNH
UnitedHealth Group
Last Price:
$419.96
Seasonality Move:
9.21%
Sell
46
Innate Pharma SA (IPHA)
is a Sell
Is Innate Pharma SA a Buy, Sell or Hold?
-
The current Innate Pharma SA [IPHA] share price is $1.98. The Score for IPHA is 46, which is 8% below its historic median score of 50, and infers higher risk than normal.
-
IPHA is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
14
UnitedHealth Group (UNH)
is a Sell
Is UnitedHealth Group a Buy, Sell or Hold?
-
The current UnitedHealth Group [UNH] share price is $418.64. The Score for UNH is 14, which is 72% below its historic median score of 50, and infers higher risk than normal.
-
UNH is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing an extreme reading that indicates risk could be especially high.
IPHA Stock Price Chart
What is Innate Pharma SA's stock price today?
-
The Innate Pharma SA share price today is $1.98Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and IPHA is experiencing selling pressure, which indicates risk of future bearish movement.
UNH Stock Price Chart
What is UnitedHealth Group's stock price today?
-
The UnitedHealth Group share price today is $418.64Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and UNH is experiencing slight buying pressure.
IPHA Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.01 | Buy |
| Relative Strength Index (14 RSI): | 53.3 | Buy |
| Chaikin Money Flow: | -29165 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (1.81 - 1.99) | Buy |
| Bollinger Bands (100): | (1.69 - 2.15) | Buy |
UNH Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -22.6 | Sell |
| Relative Strength Index (14 RSI): | 27.72 | Sell |
| Chaikin Money Flow: | 1360368 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (460.3 - 572.94) | Sell |
| Bollinger Bands (100): | (478.35 - 562.05) | Sell |
IPHA Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 1.96 | Buy |
| 20-day SMA: | 1.89 | Buy |
| 50-day SMA: | 1.99 | Sell |
| 200-day SMA: | 2 | Sell |
| 8-day EMA: | 1.96 | Buy |
| 20-day EMA: | 1.93 | Buy |
| 50-day EMA: | 1.94 | Buy |
| 200-day EMA: | 2.04 | Sell |
UNH Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 468.26 | Sell |
| 20-day SMA: | 516.75 | Sell |
| 50-day SMA: | 504.86 | Sell |
| 200-day SMA: | 547.7 | Sell |
| 8-day EMA: | 459.11 | Sell |
| 20-day EMA: | 494.87 | Sell |
| 50-day EMA: | 509.3 | Sell |
| 200-day EMA: | 528.67 | Sell |
Innate Pharma SA Earnings Growth & IPHA Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
UnitedHealth Group Earnings Growth & UNH Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.25 per share, an increase next quarter of $0.76 per share, a decrease this year of $0.84 per share, and an increase next year of $4.18 per share.
Innate Pharma SA Technical Analysis
| Apr 11 | Apr 14 | Apr 15 | Apr 16 | Apr 17 | Apr 21 | Apr 22 | Apr 23 | Apr 24 | Apr 25 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | ||||||||||
| 11 | 14 | 15 | 16 | 17 | 21 | 22 | 23 | 24 | 25 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
UnitedHealth Group Technical Analysis
| Apr 11 | Apr 14 | Apr 15 | Apr 16 | Apr 17 | Apr 21 | Apr 22 | Apr 23 | Apr 24 | Apr 25 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | ||||||||||
| 11 | 14 | 15 | 16 | 17 | 21 | 22 | 23 | 24 | 25 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||